Fortis Hospital, Shalimar Bagh – India
About Dr. Amit Verma
Dr. Amit Verma is a distinguished and pioneering figure in Indian cancer care, widely regarded as a leading molecular oncologist in India. With over two decades of experience, he has dedicated his career to integrating advanced science with compassionate, personalised patient care. Dr. Verma is the Founder and Director of the Dr. AV Cancer Institute in Gurgaon, where he champions precision oncology. His approach is rooted in the belief that every cancer is unique, utilising cutting-edge genomic and molecular profiling to design tailor-made treatment plans. Having trained at premier global institutions like AIIMS (New Delhi) and MD Anderson Cancer Center (USA), he has been instrumental in establishing India’s first Molecular Oncology Tumour Boards and shaping national cancer policies, making him one of the most sought-after experts for complex or late-stage cancer diagnoses.
Qualifications & Credentials
Medical Degrees
- MD (Clinical Biochemistry/ Cancer Medicine): All India Institute of Medical Sciences (AIIMS), New Delhi, India (2002-2004)
- MBBS (Bachelor in Medicine and Surgery): S.M.S. Medical College, Rajasthan, India (1995-2001)
- Fellowship in Experimental Therapeutics/ Cancer Medicine: UT MD Anderson Cancer Center, Houston, TX, USA (2005-2007)
- Fellowship in Cancer Research: Ramalinga Swamy Fellowship, Department of Biotechnology, Government of India (2007)
- Clinical Internship (Internal Medicine): UT Health Science Center (UTHSC), Houston, TX (2008-2009)
- ESMO Medical Oncology Certification: European Society of Medical Oncology, Switzerland (2024)
- MRCP (UK) SCE Medical Oncology: Royal College of Physicians, UK (2024)
- MRCP (UK) Internal Medicine: Royal College of Physicians, UK (2023-2025)
- ACMO (Molecular Oncology): Sidney Kimmel Cancer Centre, Thomas Jefferson University, Philadelphia, USA (2023)
- ECFMG Certification: Educational Commission for Foreign Medical Graduate, Philadelphia, PA, USA (2007)
Areas of Expertise
Major Cancer Types Treated
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancers (Colon, Stomach, Pancreatic)
- Gynaecological Cancers (Ovarian, Uterine)
- Prostate Cancer
- Sarcomas
- Carcinoma of Unknown Primary (CUP)
- Hereditary and Familial Cancers
- Precision Oncology
- Molecular Oncology
- Cancer Genetics and Genomics
- Targeted Therapy
- Immunotherapy
- Hereditary Cancer Risk Assessment
- Liquid Biopsy Analysis
- Comprehensive Genomic & Molecular Profiling
- Next-Generation Sequencing (NGS)
- Personalised Treatment Planning
- Liquid Biopsy for diagnosis and monitoring
- Molecular Tumour Board Consultations
- Gene Signature and Expression Analysis
- Management of Advanced, Relapsed, or Refractory Solid Tumours
Professional Experience
Current & Past Hospital Affiliations
Current Affiliations:
- Founder & Director: Dr. AV Institute of Personalized Therapy & Research, Gurgaon
- Principal Consultant, Molecular Oncology and Cancer Genetics: Max Institute of Cancer Care, Delhi
- Chief Medical Director: Molecular Quest Healthcare Pvt. Ltd., Gurgaon
- Director, Research & Development: HealthCare Global (HCG) Oncology Hospital, Bangalore
- Head & Senior Consultant, Molecular Oncology: International Oncology, Fortis, Noida
- Consultant, Genetic Medicine: Sir Ganga Ram Hospital, New Delhi
- Physician, Internal Medicine: UT Health Science Center, Houston, TX, USA
- Senior Resident: Maulana Azad Medical College (MAMC), New Delhi
- Resident: All India Institute of Medical Sciences (AIIMS), New Delhi
- Course Director: Fellowship in Medical and Molecular Oncology, Max Institute of Medical Education
- Thesis Supervisor: Guided multiple MSc (Clinical Research) and DNB (Surgical Oncology) candidates.
- Principal Investigator & Co-Investigator: Led and participated in numerous national and international clinical trials for solid tumours, including breast cancer.
- Mentor and Educator: Trained hundreds of oncologists in India on targeted therapy and immunotherapy.
- Policy Advisor: Advised on national policies for cancer research and treatment in India.
- Pioneered the establishment of the first Personalized Cancer Medicine Clinic in India.
- Instrumental in setting up the first Molecular Oncology Tumour Board in India.
- Holds a U.S. patent for "Methods for Treating Cancer Targeting Transglutaminase."
- Recognised as one of the first few dedicated molecular oncologists in the country.
Awards & Recognitions
National & International Awards
- Goodwill SDG Ambassador for Good Health and Well-Being: United Nations Assembly, WHO, The Commonwealth & NITI AAYOG (2021)
- Ramalinga Swamy Fellowship Award: Department of Biotechnology, Government of India (2007)
- Young Scientist Award: American Association of Indian Scientists in Cancer Research (AAISCR), USA (2007)
- Geeta Mittal Gold Medal Award for Best Resident in Oncology: AIIMS, New Delhi (2005)
- Multiple First Place awards in Multi-Disciplinary Tumour Board presentations at national conferences focusing on Breast Cancer, Sarcoma, and Gynaecological Malignancies.
- First Place in Doctor’s Dilemma: American College of Physicians, USA (2009)
- Recognised by numerous scientific forums for contributions to Molecular Oncology in India.
Research & Publications
With over 40 scientific publications, Dr. Verma is a significant contributor to cancer research.US Patent
- Methods for Treating Cancer Targeting Transglutaminase (United States Patent Number US 8,299,040 B2, 2012)
- Molecular Methods in Clinical Oncology – Basics (Clinical Oncology. Viva Voce, OSCEs and ESMO Exam Compendium, 2020)
- Genetic testing in Cancer diagnosis (Recent Advances in Surgery Vol 15, 2018)
- Molecular Oncology: Application in Breast Cancer (Breast Cancer Update, 2014)
- Drug resistance by cancer cells- a new perspective (New Research Communications on Cancer Drug Resistance)
- As Principal Investigator: Led trials on the clinical utility of Canscript and genomic profiling in predicting treatment response in advanced solid tumours (PREDICT One).
- As Co-Investigator: Participated in Phase III global trials for triple-negative breast cancer, involving agents like Atezolizumab (immunotherapy) and Pimasertib (targeted therapy).
Patient Success Stories & Testimonials
Notable Cases Handled
- Successfully identified rare genetic mutations in patients with advanced cancers, leading to effective targeted therapy after standard treatments failed.
- Pioneered the use of liquid biopsy to monitor treatment response and detect recurrence non-invasively.
- Empowered countless families with hereditary cancer risk by providing clear genetic counselling and screening protocols.
- “After being told there were no more options, Dr. Amit Verma’s precision oncology approach was a ray of hope. He analysed my tumour’s genetics and found a targeted therapy that has given me a new lease on life. His compassion and clarity are unmatched.” - Priya S.
- “We came to Dr. Verma for a second opinion on my father’s complex lung cancer. He explained everything with such patience and detail, making us feel empowered. The personalised plan he created has resulted in fewer side effects and better control of the disease.” - Rohan Mehra
- “Dr. Verma is more than just a doctor; he is a true partner in your fight against cancer. He blends deep scientific knowledge with genuine care. Thanks to his guidance on genetic testing, my family now has a clear plan for prevention.” - Anjali Gupta
Treatment Approach & Philosophy
Patient-Centred Care
- Dr. Verma is committed to a human-centred approach, believing that compassionate and transparent communication is as crucial as the treatment itself. He empowers patients and their families with clear, actionable information, ensuring they are active participants in their care journey, especially when facing complex or late-stage diagnoses.
- Dr. Verma’s practice is at the forefront of medical innovation. He leverages the latest advancements in molecular biology, including Next-Generation Sequencing (NGS), liquid biopsy, gene expression profiling, and computational biology, to move beyond one-size-fits-all treatments and deliver truly personalised cancer care.
Treatment Costs
| Treatment / Test | Estimated Cost (in INR) | Estimated Cost (in USD) |
| Comprehensive Genomic Profiling (CGP/NGS) | ₹1,50,000 - ₹3,50,000 | $1,800 - $4,200 |
| Targeted Therapy (per month/cycle) | ₹1,00,000 - ₹4,00,000+ | $1,200 - $4,800+ |
| Immunotherapy (per cycle) | ₹1,50,000 - ₹3,00,000 | $1,800 - $3,600 |
| Liquid Biopsy Test | ₹50,000 - ₹2,00,000 | $600 - $2,400 |
International Patient Assistance
Language Support
- The Cancer Rounds team provides dedicated support for international patients, including interpretation services to ensure clear communication with Dr. Verma and his team.
- Our team assists with all necessary documentation for medical visas, as well as travel arrangements, airport transfers, and comfortable accommodation for the patient and their family.
- Dr. Verma is available for pre-treatment virtual consultations. This allows international patients to receive a detailed second opinion, discuss their case, and understand the proposed treatment plan before travelling to India.
Frequently Asked Questions
A molecular oncologist, like Dr. Amit Verma, is a medical oncologist who sub-specialises in understanding the genetic and molecular changes that drive cancer. While a medical oncologist treats cancer with drugs, a molecular oncologist uses advanced genomic tests to identify specific targets in a patient's tumour and selects personalised treatments like targeted therapy or immunotherapy for better outcomes.
Precision oncology is an advanced approach to cancer treatment where therapies are tailored to the specific genetic makeup of a patient's tumour. Instead of treating all lung cancers the same, for example, it identifies the unique mutations driving the cancer and uses drugs that specifically target those mutations.
You should consider consulting Dr. Verma if you or a loved one has an advanced, rare, or relapsed cancer, if standard treatments are not working, if you are seeking a second opinion, or if you have a strong family history of cancer and wish to understand your genetic risk.
A liquid biopsy is a simple blood test that can detect cancer cells or DNA from a tumour circulating in the blood. Dr. Verma uses it to find cancer-specific mutations to guide treatment, monitor how well a therapy is working, and check for cancer recurrence without needing an invasive tissue biopsy.
Yes, Dr. Amit Verma is widely regarded as one of the leading and top molecular oncologists in India. His pioneering work in establishing personalised cancer medicine clinics, his international training, and his research contributions have placed him at the forefront of modern cancer care in the country.
While Dr. Verma has extensive experience with common solid tumours like breast, lung, and GI cancers, his expertise in molecular oncology is applicable across a wide range of cancers. His approach focuses on the genetic drivers of the disease, not just the organ of origin.
You can easily book an appointment with Dr. Amit Verma for a consultation or second opinion by contacting the Cancer Rounds. The team will assist you with scheduling both in-person and virtual appointments.
